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Simple Summary: FLASH radiotherapy uses radiation at ultra-high dose rates to achieve normal
tissue sparing compared to radiation at conventional dose rates. However, the spatiotemporal
variation in dose delivery for proton pencil-beam scanning treatments presents a challenge in terms
of defining and achieving high dose rates. This article describes a model that can be used to examine
possible FLASH effects in pencil-beam scanning using a mechanistic approach. The mechanism
of radiolytic oxygen depletion is the focus of this study, however the approach can be applied
more widely.
Abstract: FLASH radiotherapy is a rapidly developing field which promises improved normal
tissue protection compared to conventional irradiation and no compromise on tumour control. The
transient hypoxic state induced by the depletion of oxygen at high dose rates provides one possible
explanation. However, studies have mostly focused on uniform fields of dose and there is a lack
of investigation into the spatial and temporal variation of dose from proton pencil-beam scanning
(PBS). A model of oxygen reaction and diffusion in tissue has been extended to simulate proton
PBS delivery and its impact on oxygen levels. This provides a tool to predict oxygen effects from
various PBS treatments, and explore potential delivery strategies. Here we present a number of case
applications to demonstrate the use of this tool for FLASH-related investigations. We show that
levels of oxygen depletion could vary significantly across a large parameter space for PBS treatments,
and highlight the need for in silico models such as this to aid in the development and optimisation of
FLASH radiotherapy.
Keywords: FLASH radiotherapy; proton pencil-beam scanning; oxygen depletion
1. Introduction
The development of proton pencil-beam scanning (PBS) was a major breakthrough
in particle therapy [1]. The use of tightly focused pencil beams, scanned over a target
volume, allows for unique sparing of normal tissue proximal to the tumour and improved
efficiency compared to passive scattering techniques. Currently, the field of particle therapy
could be facing its next major breakthrough—FLASH radiotherapy [2]. The exploration of
ultra-high dose rates during the 1970s and 1980s led to promising results demonstrating
improved sparing of normal tissue compared to conventional dose rates [3,4]. This was
attributed to a depletion of molecular oxygen, at a rate too fast for cells to be re-oxygenated
via diffusion of oxygen from nearby blood vessels, thus resulting in a state of transient
hypoxia to produce the apparent sparing effect [5,6]. The issue of a potential reduction in
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tumour control that existed, and the resultant reluctance to develop the technique further,
has been addressed more recently since the resurgence of interest in ultra-high dose rate
irradiation in 2014 for FLASH sparing [2,7]. Despite the major advantages of each of these
breakthrough treatment modalities, the avenue that exists from combining the techniques
remains under-explored.
A number of studies have demonstrated the FLASH effect in various in vitro and
in vivo systems [3,4]. Although some recent studies have shown that the radiolytic deple-
tion of oxygen may not provide a full explanation for the observed sparing [8,9], it has
been demonstrated that depletion takes place to some extent (which may be amplified in
some biological systems [10]). Moreover, many studies have shown the FLASH effect to
be an oxygen-dependent process [11,12], with other proposed mechanisms involving the
production and reaction of reactive oxygen species [13,14]. Here we present a tool that is
able to investigate oxygen effects from radiation, and which can be expanded to include
additional oxygen-related mechanisms as they are elucidated.
Various radiation modalities have been investigated for FLASH, however relatively
few have focused on proton spot scanning. The unique spatial and temporal variations
of dose deposition in PBS presents a challenge in terms of defining and meeting a dose
rate threshold. Studies by van Marlen et al. [15] and van de Water et al. [16] have each
looked at spatial dose rate distributions for various PBS treatment plans and deliveries,
to determine how FLASH dose rates could be achieved. A framework for defining dose
rates during PBS treatments has since been developed by Folkerts et al. [17]. More recently,
Zou et al. [18] have used clinical and FLASH proton PBS plans to determine the effective
field dose rate and its dependence on various delivery parameters. By considering a
FLASH dose rate threshold of 40 Gy/s, they found FLASH could only be achieved for
single-layer plans with minimal energy switching and time between spots. In this paper,
we present a model that is able to investigate the impact of similar delivery parameters
using a more biological perspective, looking specifically at the effects of radiation-induced
oxygen depletion. By applying the dose-time structures of PBS delivery to a model of
oxygen depletion, we can investigate the possibility of FLASH sparing based on changes
in oxygen-enhanced radioprotection as opposed to a dose rate threshold. Furthermore, this
model is able to explore the possibility of FLASH sparing from successive high-dose-rate
spots, regardless of a high overall dose rate for the treatment.
It was shown in our previous work that defining a threshold solely in dose rate is an
oversimplified approach to parameterising the FLASH effect [19]. Instead, FLASH sparing
exists within a complex parameter space involving the dose, dose rate, radiolytic depletion
parameters, as well as biological parameters which determine the initial oxygen tension
before irradiation and the rate of recovery. Instantaneous dose rates in PBS can be high,
but although dose rates in each proton spot may be above the supposed FLASH thresh-
old, limitations in the dose (usually only ∼2 Gy per fraction) or other parameters could
explain why we do not see a FLASH effect in individual spots for current spot scanning
treatments [20]. Our previous work showed the impact of each of these parameters, and the
criteria necessary to achieve sparing, using a model of oxygen diffusion and reaction in
tissue irradiated at varying dose rates. This reaction-diffusion model provides a framework
for FLASH-related investigations, and is the basis of this work in which we superimpose
a spot scanning model to demonstrate how oxygen depletion effects in proton treatment
plans could be explored.
The spot scanning model introduces a new set of parameters and timing characteristics.
During a PBS treatment, the monoenergetic beam is scanned across the cross-sectional
area of the target and spots of the dose are delivered one after another [21]. The depth
of irradiation is determined by the energy of the beam. After a single layer is scanned,
the beam energy is reduced to paint the next layer. For treatments with multiple fields,
the process is repeated at different beam angles. Although a given treatment plan provides
a three-dimensional map of the dose within the patient, the time characteristics of the
dose delivery are not described. The scanning implementation is generally optimised
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based on the efficiency of delivery. The model demonstrated here could be used to explore
the impact of different delivery patterns on oxygen depletion effects and a potential shift
in the way these scanning parameters are optimised, based on exploiting any possible
oxygen-depletion-induced sparing of normal tissue.
A further point of interest is the concept of transmission compared to Bragg peak
FLASH for proton spot scanning. Transmission FLASH uses a monoenergetic beam of
higher energy that passes through the patient, delivering the dose from the entrance
plateau rather than the Bragg peak. This has mostly been looked into so far [15], since
it is better able to replicate electron delivery conditions from recent FLASH studies [7].
Bragg peak FLASH makes use of reduced dose downstream of the target, combining the
dose conformality of PBS with the normal tissue sparing of FLASH. However, maintaining
high dose rates is more complex due to the degrading of the beam energy and proton
losses [18]. Comparison of transmission and Bragg peak FLASH, and their respective
impact on oxygen depletion, presents another area that can be investigated using this
model. Furthermore, the spatiotemporal features of this model are not limited to spot
scanning techniques; a further area to study is the potentially synergistic combination of
FLASH and minibeam radiation therapy using protons [22]. In this report, we outline the
main workings of the model and provide a number of case examples to demonstrate its
possible application, followed by a discussion on the further opportunities for investigation
using this framework.
2. Materials and Methods
2.1. Oxygen Reaction-Diffusion Model
The basis of this work is a one-dimensional model of oxygen diffusion and reaction
in tissue, which combines Fickian diffusion with terms to describe the metabolic and




= De f f
∂2C
∂x2
− [rmet + rrad], (1)
where x is the position (in metres), t is time (in seconds), C is oxygen concentration (in
mol/m3) and De f f is the effective diffusivity (in m2/s). The rate of reaction terms, rmet and
rrad, describe the metabolic and radiation-induced consumption of oxygen respectively (in
mol/m3/s). Both are defined as positive for destruction. A schematic diagram is shown in
Figure 1.
The metabolic consumption of oxygen is modelled using Michaelis-Menten style kinet-





where k is the metabolic rate constant (in mol/m3/s), which describes the maximum rate
of metabolic consumption, and ks is the saturation constant (in mol/m3), which describes
the concentration at which the rate of consumption saturates. Here, the kinetics become
zero-order when ks  C (as r → k), and become first-order when ks  C (as r → kks C).
The radiolytic consumption of oxygen is modelled using a two-stage lumped reaction.
First, the interaction of radiation with cells produces radiolytic species A at a rate given by:
rA = k1Ḋ− k2[A]C, (3)
where Ḋ is the dose rate (in Gy/s), k1 is the reaction rate constant (mol/m3/Gy), and [A]
gives the concentration of radiolytic species A. Second, intracellular oxygen reacts with A
resulting in its depletion [23], at a rate given by:
rrad = −k2[A]C, (4)
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where k2 is the reaction rate constants for the second stage (in m3/mol/s).
Figure 1. Schematic diagram of the oxygen diffusion-reaction model, showing radial diffusion from
a capillary along an orthogonal grid of nodes. An adjacent capillary is shown, where the distance
between two capillaries is 2L. A node width of ∆x = 1 µm and system length of L = 50 µm was used
for all simulations. The figure is reproduced from Rothwell et al. [19].
The solution technique is a cellular automaton [24]. A grid of nodes is supplied with
oxygen via a capillary at x = 0. A series of time-steps are applied to simulate diffusion of
oxygen across the nodes from the capillary, metabolic consumption of oxygen inside the
nodes, and radiation-induced consumption during irradiation.
The state of each node is characterised by its concentration of oxygen. Dissolved
oxygen concentrations (in mol/m3) can be converted into partial pressure values (in mmHg
or % O2) using Henry’s Law [25]. To evaluate the change in relative radiosensitivity, this
work has used the dependence of the oxygen enhancement ratio (OER) on oxygen tension
as given by the Grimes & Partridge model [26], which fits well with the experimental data:




where p is the oxygen partial pressure (in mmHg), and values of 1.6 and 0.26 mmHg−1 have
been established for φ0φD and ψ respectively. Using this parameterisation, the maximum
OER (under aerated conditions) is 2.6 and minimum OER (under anoxic conditions) is 1.0,
giving a maximum OER shift of 1.6.
The effects of varying each parameter involved in the model were shown previ-
ously [19]. For the purposes of this study, the parameters in the oxygen reaction-diffusion
model were kept constant for all the following simulations to solely demonstrate delivery
effects on the oxygen levels. However, these can be altered to match tissue-specific char-
acteristics of the site under investigation if the data are available. The parameter values
used in the following case studies were based on normal tissue literature values, and were
generally chosen to sit in the middle of the range of literature values. The parameters in
the model and the values used in the following examples are summarised in Table 1.
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Table 1. Parameter definitions and values used in simulations.
Symbol Definition Value Used References
Ḋ Dose rate [Gy/s] / /




2 × 10−9 m2/s [27]
ε
Fractional voidage (space
available for oxygen diffusion) 0.2 [28,29]
τ
Tortuosity factor (non-linearity
of diffusion path) 1.4 [28,29]
p0
Oxygen tension in the capillary
(at x = 0 in oxygen model) [mmHg] 40 mmHg [30]
k












Oxygen depletion rate constant
[m3/mol/s]
105 m3/mol/s [19]
L Length of node system [µm] 50 µm [35]
∆x Node width [µm] 1 µm /
∆t Time-step size [s] 10−5 s /
2.2. Spot Scanning Model
The spatial and timing information for each spot in a treatment plan can be contained
in an influence matrix, which is a two-dimensional array showing the contribution of each
spot to each voxel in the treatment volume. The influence matrix is derived using scripting
to calculate and export the dose from each pencil beam individually. The dose is calculated
using a treatment planning system, Eclipse (Varian Medical Systems, Palo Alto, CA, USA),
with a clinically-used analytical beam model. The example given in Figure 2 shows a
clinical base of skull plan with four beams and a prescription dose of 70.2 Gy delivered in
39 fractions of 1.8 Gy. A section of the influence matrix for this plan is shown in Figure 2b.
The full array contains a column for each voxel in the dose distribution and a row for each
spot in the plan. The three-dimensional voxel array is reshaped into a one-dimensional
list of voxel numbers (generally in order of increasing z, then by increasing x, then by
increasing y) to form the columns. Spot numbers are assigned to each spot in the plan in
the order they are delivered, to form the rows. By using the timing of each spot along the
vertical axis, the temporal distribution of dose delivery to a given voxel can be visualised
by reading down the column for that voxel.
To simulate these unique timing characteristics, the model considers four main contri-
butions to time:
1. Time to deliver the dose at the spot location i, tispot (∼1–10 ms);
2. Time to move from spot i to spot j, t(i→j)scan (∼1–2 ms, or approximated using the distance
between spots and a scanner speed of ∼10 m/s [21]);
3. Time to change the energy layer, tlayer (highly variable for different systems [1], values
from 50 ms up to 1 s were tested here);
4. Time taken to change the beam position to irradiate the next field, tbeam (dependent
on many treatment factors).
For the latter beam changing time, since the time taken for the nodes to recover back
to a steady state of oxygen tension is on a much shorter timescale, this can be assumed
to remain fixed at a value sufficiently large to allow for the full recovery of the nodes.
Computational effort can be saved by discontinuing a further simulation once the steady
state is reached, and so a beam change time of 10 s was used here. These timings accumulate
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spot + tlayer + t
k
spot etc. Each spot is assigned
a time-point to start irradiating, at which point the nodes begin to receive the calculated
dose from that spot for its delivery duration.
Figure 2. (a) A clinical base of skull treatment plan showing the contribution of dose from four beams (left) and the full dose
map (right) overlayed onto a CT slice. Dose distributions are generated using Eclipse (Varian Medical Systems, Palo Alto,
CA, USA). (b) Extract from the corresponding influence matrix showing the contribution of each spot to each voxel in the
treatment volume. Each voxel in the three-dimensional treatment plan is reshaped into a one-dimensional list by assigning
a number (in order of increasing z, then by increasing x, then by increasing y) to form the columns of the influence matrix.
The list of spots, in the order they are delivered, make up the rows.
For each simulation, the oxygen reaction-diffusion model is superimposed onto the
model of spot scanning. However, as proton spot size is on the order of millimetres [21],
and oxygen diffusion in tissue is on a scale of micrometres [35,36], this presents a multi-
scale computational challenge. This can be overcome by placing the system of nodes at
different locations within the spot scanning model to investigate the oxygen depletion
effects in different cases under different spot conditions. The timescales of each model
should also be taken into account, as the time structure of the reaction-diffusion model is
limited by its time-step size. The spot scanning simulation can operate with a time structure
down to the order of milliseconds, so a time-step size of at least an order of magnitude
smaller than this is required to ensure numerical stability. This parameter can be adjusted
as appropriate.
The grid of nodes receives the dose from a number of proton spots, calculated using the
influence matrix, at their assigned timepoints. For a given spot with the centre sufficiently
close to the node position in the x-y plane, if the spot is in the same energy layer as the
Radiation 2021, 1 296
grid of nodes, the dose received by the nodes will be within the spot’s Bragg peak. If the
spot is at a greater depth than the nodes it will contribute part of its entrance dose, while if
the spot is at a shallower depth the nodes will experience almost no dose from the spot.
During a simulation, the nodes at a fixed position will receive a proportion of the dose
from each spot, depending on their relative distance in the x-y plane and are further scaled
by whether this is an entrance dose, peak dose, or if the nodes are past the distal edge of
the spot. This dose information is contained within the influence matrix.
By altering the position of the nodes within the three-dimensional spot map, we can
investigate oxygen depletion effects in different areas of the treatment, such as within the
tumour target volume, at shallower depths occupied by normal tissue, or at the distal edge
of a beam where an organ at risk may be situated. Examples of different representative
positions were simulated. An interface has also been developed to allow the user to view
the CT slices and dose maps of the treatment plan (for both the total dose and from each
individual beam), specify structures to contour, then select a point in the plan for which to
generate oxygen depletion data. This allows the user to investigate the depletion effects in
specific structures or regions in the plan.
2.3. Case Applications
Example applications of the model have been provided to demonstrate its use as a tool
for FLASH-related investigations. The clinical plan in Figure 2 was used to highlight some
of these. Non-clinical abdominal plans were also generated for the same treatment site
to show how the model can be used to investigate different delivery methods for FLASH
using either transmission beams or multiple layers of Bragg peaks. Each of these plans
was optimised to reduce dose to normal tissue. A prescription dose of 40 Gy delivered
in 5 fractions of 8 Gy each was used. The transmission delivery used three beams (each
with a single energy layer of 245 MeV and ∼180 spots), and the Bragg peak delivery
used two beams (with energies ranging ∼130–180 MeV and up to ∼100 spots per layer).
Influence matrices from both plans were input into the model to show how various delivery
parameters could be investigated.
Another use of this model is to explore the concept of delivery optimisation based on
oxygen depletion. A typical spot scanning pattern, delivered row-by-row in the x-y plane
before changing energy to paint the next energy layer, is generally optimised for efficiency.
However different patterns and delivery techniques may be more optimal for inducing
oxygen depletion. Various methods and parameters were investigated here to demonstrate
the capabilities of the model, such as changing the order in which the spots are delivered,
changing the timing parameters, or the use of single vs. multiple beams.
The timing characteristics of dose delivered to a single voxel can be determined from
each column of the influence matrix. The rows can be reordered to ensure the dose is
delivered consecutively to maximise oxygen depletion, allowing minimal time for recovery.
However, while this can easily be achieved for a single voxel, optimising the dose delivery
for multiple voxels across the plan is not straightforward. Furthermore, constraints from
the delivery parameters, such as the time to change energy layer, must also be considered.
Various optimisation strategies can be used and their impact on the oxygen depletion can
be tested using this model.
A useful approach to compare the outcome for different delivery strategies in the
model is to plot a dose-OER histogram (DOH) which shows the cumulative dose delivered
at each OER. The area under a DOH curve gives an indication of the overall decrease in
radiosensitivity during the treatment. For a conventional plan, it is expected that the full
dose is delivered at approximately the same OER, while for a FLASH delivery with oxygen
depleting characteristics, the dose would be delivered at different OER values. A lower
DOH area therefore suggests improved sparing. These histograms can be produced for a
specific node or by averaging over the nodes. Corresponding values of OER (for that node)
and dose at each timepoint are ordered by decreasing OER, then the cumulative dose is
calculated. Examples are given in the following section.
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3. Results
3.1. Clinical Plan—Oxygen Depletion in Different Regions
Oxygen depletion in three positions of the treatment plan in Figure 2a were simulated:
within the target volume, in the entrance region of one of the beams, and in the brainstem
at the distal edge of one of the beams. Plots for OER as a function of time are shown in
Figure 3 for an example the node position at 25 µm from the capillary. Nodes at a distance
of approximately 20–30 µm were found to undergo the greatest reduction in OER in this
example; this is roughly expected from the quasi-hyperbolic variation of OER with oxygen
tension [26], where there exists an initial tension at which a maximum change in OER is
achieved for a given depletion. The peaks and troughs in OER show that the timescales for
the spot delivery and reaction-diffusion models are relevant to each other.
Figure 3. Dose distribution (left) for the clinical base of skull plan in Figure 2 annotated to show three points where OER
data were simulated. The plots (right) show the change in OER and the cumulative dose over the duration of the simulated
treatment for the three points in the plan: (a) within the GTV, (b) in a beam entrance, or (c) in the brainstem. The blue line
shows OER as a function of time for the node position at 25 µm from the capillary in the oxygen diffusion model. The black
lines show the cumulative dose at that point over the course of the treatment.
As expected from the four beams in the treatment simulation, there is a gross structure
in the OER curves consisting of four troughs where the nodes, particularly in the cases
of the GTV and brainstem, experience prolonged oxygen depletion from consecutive
spots. The width of these overall troughs is comparable to the duration of the beam-
on time, suggesting that suppression of oxygen enhancement could be maintained for a
significant proportion of the treatment. The fine structure shows some large drops in OER,
corresponding to spots delivered relatively close to the nodes and in the same energy layer.
Smaller peaks may correspond to spots in the same layer delivered further away in the x-y
plane, or be due to the entrance dose of spots delivered distal to the node position.
From the three examples shown in Figure 3, the greatest OER change over the treat-
ment is in the GTV, while there is significantly less change in the beam entrance. However,
even these maximum OER shifts remain over a small scale of ∼0.01, as expected for a
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clinical treatment. The shift in OER from steady state can be measured using the model for
every time point over the treatment, for each node. The maximum or average shift over
the treatment duration (for each node) can also be determined.
3.2. FLASH Plans—Transmission and Bragg Peak
Example dose-OER histograms are given in Figure 4 for the transmission and Bragg
peak plans. These were measured in the PTV of each plan using a scan time of 1 ms and a
layer change time of 1 s, for the node at 25 µm from the capillary. The model can output
the area under the DOH curve; for these examples using a total dose of 8 Gy per fraction,
the areas were 17.5 and 17.9 Gy for the transmission and Bragg peak plans, respectively.
Figure 4. Non-clinical dose distributions (left) generated to deliver 8 Gy per fraction to the same abdominal treatment site
using either multiple layers of Bragg peaks (top left) or 245 MeV transmission beams (bottom left). Example dose-OER
histograms (right) were calculated for a single point in the PTV of both plans, to show the OER as as a function of cumulative
dose at that point. The area under the OER curve gives an indication of the overall decrease in radiosensitivity during the
plan. Results were generated for the node 25 µm from the capillary.
Dose-OER histograms can be used to quantify the impact of varying delivery pa-
rameters, such as the time to scan from one spot to the next, Tscan, or the time to change
energy layer, Tlayer. Examples are shown in Figure 5. For the Bragg peak plan, the smallest
DOH area was obtained using the lowest values of both the scan time and layer change
time. The area increases with either of these times, however increasing the scan time
by 1 ms causes a much larger increase in area for a layer change time of 0.05 s than for
1 s. In contrast, for the transmission plan, the effect of increasing the scan time by 1 ms
is insignificant.
The use of multiple beams may have implications for achieving FLASH sparing [37],
and so the model can be used to investigate the impact of using different numbers of
beams. Example DOHs for both FLASH plans are shown in Figure 6, comparing the use of
one of the beams delivering the full 8 Gy fraction dose, with the delivery from all beams.
As expected, for both plans the reduction in overall treatment time for the single-beam
approach means that more dose is delivered at a reduced OER, resulting in a significantly
reduced DOH area. Similar investigations into the effect of single- or hypo-fractionation
dose delivery can also be performed by adjusting the fraction size in the model [37].
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Figure 5. Dose-OER histograms calculated for a single point in the PTV of the Bragg peak (left) and transmission (right)
plans shown in Figure 4, using different values of the time taken to scan between consecutive spots, Tscan, and the time
taken to change the energy layer, Tlayer. Different layer change times were not simulated for the single-layer transmission
plan. Results were generated for the node 25 µm from the capillary.
Figure 6. Dose-OER histograms calculated for a single point in the PTV of the Bragg peak (left) and transmission (right)
plans shown in Figure 4, using either the original number of beams (two for the Bragg peak plan, three for the transmission
plan), or a single beam from the plan delivering the full 8 Gy dose per fraction. Results were generated for the node 25 µm
from the capillary.
3.3. Delivery Reordering
Various re-delivery strategies were tested using this model to investigate the effects of
delivering the same set of spots (and therefore the same dose distribution) in a different
order. The results in Figure 7 show an example case of reordering the delivery of the
spots used in the clinical base of skull plan. The original order was the default delivery
generated by the delivery system (scanning row-by-row in the x-y plane for a single layer,
then changing the energy layer and scanning row-by-row again in the next). The method
of reordering tested here was to order all of the spots row-by-row in the x-y plane across
all energy layers (within each beam), such that energy changes were introduced between
consecutive spots. Both orders were tested for layer change times of 0 and 1 s, while keeping
the scan time between spots constant at 1 ms. The results in Figure 7 were generated for a
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point in the GTV of the plan, and for the node 25 µm from the capillary. Figure 7a shows
the change in OER over the course of the treatment for both delivery orders, using a layer
change time of 0 s. Figure 7b shows dose-OER histogram results for each of the layer
change times tested, for both orders of delivery.
Figure 7. (a) OER as a function of time for a single point in the GTV for the base of skull plan (point a in Figure 3). The OER
profile is shown for two different methods of delivering the same set of spots: original results (blue) were generated by
scanning spots layer-by-layer; reordered results (red) were generated by scanning all spots row-by-row in the x-y plane
regardless of energy layer. (b) Dose-OER histograms for the original (blue) and reordered (red) orders of delivery, using
different values of the time taken to scan between consecutive spots, Tscan, and the time taken to change energy layer, Tlayer.
All results were generated for the node 25 µm from the capillary. Note that the overall dose distribution in each case is
identical, as it is only the temporal delivery that is altered.
For a layer change time of 1 s, the original order gave a lower DOH area, as expected
for a more efficient delivery with minimal layer changes. However, for a layer change time
of 0 s, the reordered DOH area was lower than the original. In this case, the OER profile for
the reordered delivery in Figure 7a shows smoother peaks (from the four beams) compared
to the original delivery with a greater micro-structure within each peak. For the reordered
delivery, with a layer change time of 0 s, all spots within the vicinity of the node position in
the plan are delivered consecutively, whereas the original delivery sequence results in a
full layer being scanned before coming back around to the node position in the next layer.
Nodes therefore have less time to recover between spots in the reordered case, resulting
in the reduced micro-structure. However, introducing a layer change time of 1 s creates
longer gaps between consecutive spots where the nodes are able to recover significantly
between spots.
4. Discussion
We have presented a method for exploring oxygen depletion effects of proton spot
scanning using a model of oxygen diffusion and reaction in tissue. The model was de-
veloped with the aim of exploring one of the most predominant hypotheses behind the
FLASH sparing effect. However, it can also be used to understand the extent of any oxygen
depletion effects that may exist in current treatments to ensure we have a benchmark to
compare FLASH-related discoveries against. This is particularly important for proton spot
scanning, where the spatial and timing characteristics make it unique compared to other
modalities generally investigated for the purposes of FLASH. The framework can also be
expanded to investigate other oxygen-dependent mechanisms that may contribute to the
FLASH sparing effect.
By solving the multi-physics problem of oxygen diffusion and consumption (on the
order of µm) combined with the proton spot irradiation (on the order of mm), we have
shown that the timescales of these two models are relevant in the context of oxygen
depletion, and that the potential biological impact predicted from the former model may
not be negligible in a typical spot scanning treatment. The model can be used to identify
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cases where the extent of depletion may lead to suppression of the OER for a significant
duration of the treatment, where a potential biological impact might be worth investigating.
Previous studies have investigated dose rate distributions of proton PBS treatments
and used the assumption that a defined average dose rate must exceed a FLASH threshold
(usually 40 Gy/s) to produce a sparing effect—e.g., using the dose-averaged dose rate [15],
the dose rate distribution in a beam [15], or the effective field dose rate [18]. While
obtaining high average dose rates should be a priority for FLASH, particularly with
the use of standardised dose rate measurements to compare with different radiation
modalities [17], to our knowledge, this is the first model that can also investigate possible
sparing from successive high-dose-rate spots causing suppression of oxygen levels, even
without the average dose rate surpassing a supposed FLASH threshold. By adopting a
more mechanistic approach for FLASH sparing, our model is able to analyse the impact of
different dose rate distributions and work towards defining the conditions under which
FLASH sparing could be achieved.
We have provided case-study applications to demonstrate differences in oxygen
depletion effects at different points in a clinical treatment plan, for hypothetical FLASH
plans, and examples of how results can be quantified. It should be emphasised that all
results provided are the outcome of a specific set of parameters tested (see Table 1) and for
specific treatment scenarios; the model can be used to simulate various delivery regimes
and measure the effect of varying any of the model parameters, perhaps to investigate
effects for different regions of the body with different compositions, or to cover the full
range of biological uncertainty for each parameter. For many of the examples, results were
given for positions within the treatment volume to demonstrate oxygen effects at points
with the greatest dose, and at the intersection of multiple beams, to highlight the temporal
effects. For investigations with the purpose of inducing the greatest OER shifts, it may be
more relevant to use points within organs at risk or other normal tissue sites.
The example results given here showed most significant shifts at 20–30 µm from the
nearest capillary. Although variation in OER was over a very small scale for these results,
even at this capillary distance, this is to be expected for the conventional delivery regime
simulated using 1.8 Gy per fraction delivered using four beams. The results here therefore
provide a benchmark to compare any FLASH-related investigations against. The model
can be used to investigate non-conventional delivery regimes which may cause a greater
shift in OER. However, these should always be weighed up against dose conformality and
other treatment considerations in radiotherapy.
Currently, the delivery of PBS treatments is generally optimised based on efficiency.
Here, we highlight the novel concept of optimising delivery based on oxygen effects
and present a tool to explore this. In the example provided in Figure 7, the plan was
reordered such that all spots were scanned row-by-row in the x-y plane, regardless of energy
layer, therefore resulting in a large number of energy changes. Using the hypothetical
assumption that energy switching can be performed instantaneously, this could result
in a large variation in OER effects over the treatment. It should be noted that this is a
single example of a number of ways the delivery could be reordered to produce a similar,
or greater, OER variation, and is simply used for illustrative purposes. Furthermore,
the effects are only shown for a single point in the target volume (to compare against the
most significant OER variation from the results in Figure 3). Optimisation strategies could
be used to investigate this further across larger sites, and determine the extent to which
OER variation is feasible from delivery reordering.
Although short delivery times are generally optimal for patient comfort and reduction
of movement, the beam-on time only makes up a small proportion of the total treatment
time, and so this could be a compromise worth making given sufficient evidence for a new
way of optimising. Furthermore, the technical procedures required to alter the delivery
sequences from the default settings may be difficult to achieve and were only simulated
in this work. However, if there is sufficient evidence for improved outcome, the practical
applications of delivery optimisation could be looked into. We have provided examples
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of how different methods of delivering the same plan result in different oxygen depletion
levels. The model provides a tool to explore this concept further.
The model applications are not limited to the example case studies given here. For ex-
ample, by altering the reaction-diffusion parameters to obtain varying levels of tissue
oxygenation or metabolism, the effects of different tissue types or conditions can be investi-
gated. Using the contoured treatment plan interface, by selecting a structure of interest it is
possible to generate oxygen depletion data using tissue-specific parameters for that site.
Given the availability of normal tissue and tumour specific data for each parameter, these
could be input into the model to investigate differential effects.
The ability of the model to incorporate spatial and temporal characteristics of the dose
means that non-conventional spot scanning techniques can also be simulated. The use of
minibeams, and particularly the combination of FLASH and minibeam radiotherapy, is a
further area of current interest [22]. Influence matrices showing spatial fractionation of a
dose across a treatment plan can be generated and passed onto the model to determine
oxygen levels at different points in the treatment, within the peaks or valleys of the
microbeam array. Moreover, the model could be used in a similar way to explore the
biological impact of spot-reduction techniques—another active area of research in proton
therapy, either for the purpose of increasing the dose rate to achieve FLASH sparing, or to
shorten treatment times [16,18].
The current challenge of Bragg peak vs. transmission FLASH can also be investigated
using comparable treatment plans for each case. While transmission beams are expected
to lead to greater sparing by maintaining a higher dose rate, the examples provided here
suggest that the best approach may not be as clear when oxygen depletion is measured.
Differences in biological effect as a result of different LET distributions from each technique
should also be considered.
The model relies on a number of assumptions outlined in Rothwell et al. [19], as well
as the assumption that the concepts included, such as the OER model, can be applied
to protons. Validation of these using experimental results remains crucial. A particular
limitation of this work is the one-dimensional nature of the oxygen model, which neglects
the three-dimensional diffusion effects from complex networks of blood vessels. However,
even in one dimension, parameters can be adjusted to imitate oxygen levels and recovery
rates at certain points within a three-dimensional system. Furthermore, the simplicity of
the model reduces the number of model parameters required, and acts as an initial guide
for possible oxygen depletion effects. A simplistic model can identify particular areas of
further investigation, for which complexity of relevant aspects can be incorporated.
This work is also limited by the lack of a direct link between changes in oxygen
concentration on a sub-voxel scale and subsequent biological response. Although models
exist to relate cellular oxygen tension to their relative radiosensitivity [26,38], the translation
of this to a patient level is poorly characterised. This allows only predictions to be made
in terms of the patient outcome for different levels of oxygen depletion during treatment.
It is crucial to establish the translation to patient outcome using in vivo and, ultimately,
patient data.
5. Conclusions
The model presented provides a tool to investigate oxygen depletion effects from
proton spot scanning. A number of case applications using clinical and non-clinical
(FLASH) treatment plans have been provided to demonstrate its use in measuring oxygen
enhancement for different delivery scenarios. The variation in results from these examples
emphasises the importance of in silico investigations over a large parameter space to
establish both the conditions needed for a FLASH effect and a benchmark to compare
FLASH-related discoveries against.
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